EN Official Journal of the European Union C 67/12

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2009, at their meeting on 4 December 2009:

Annex I List of new marketing authorisations Annex II List of renewed marketing authorisations Annex III List of extended marketing authorisations Annex IV List of withdrawn marketing authorisations Annex V List of suspended marketing authorisations

ANNEX I List of new marketing authorisations The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2009: EU-Number Product Country Date of authorisation EU/1/08/462/001/NO-006/NO Ranexa Norway 4.2.2009 EU/1/08/474/001/NO-003/NO Alisade Norway 19.1.2009 EU/1/08/474/001-003/IS Alisade Iceland 16.1.2009 EU/1/08/475/001-034 Olanzapin Mylan Liechtenstein 30.4.2009 EU/1/08/476/001-004/IS Tadalafil Lilly Iceland 16.1.2009 EU/1/08/480/001/NO-018/NO Irbesartan Krka Norway 17.2.2009 EU/1/08/480/001-018/IS Irbesartan Krka Iceland 29.1.2009 EU/1/08/481/001/NO-003/NO Kuvan Norway 5.1.2009 EU/1/08/481/001-003/IS Kuvan Iceland 25.1.2009 EU/1/08/482/001/NO-002/NO Azarga Norway 5.1.2009 EU/1/08/482/001-002/IS Azarga Iceland 26.1.2009 EU/1/08/483/001/NO-018/NO Zomarist Norway 5.1.2009 EU/1/08/483/001-018/IS Zomarist Iceland 16.1.2009 EU/1/08/484/001/NO-018/NO Icandra Norway 18.3.2009 EU/1/08/484/001-018/IS Icandra Iceland 15.1.2009 EU/1/08/488/001 Vidaza Liechtenstein 28.2.2009 EU/1/08/488/001/IS Vidaza Iceland 15.1.2009 EU/1/08/488/001/NO Vidaza Norway 20.1.2009 EU/1/08/489/001 Opgenra Liechtenstein 28.2.2009 EU/1/08/489/001/NO Opgenra Norway 24.3.2009 EU/1/08/489/01/IS Opgenra Iceland 25.3.2009 EU/1/08/490/001/NO-016/NO Pramipexole Teva Norway 5.2.2009 EU/1/08/490/001-016 Pramipexole Teva Liechtenstein 28.2.2009 EU/1/08/490/001-016/IS Pramipexole Teva Iceland 23.2.2009 EU/1/08/491/001-080 Rasilez HCT Liechtenstein 28.2.2009 EU/1/08/491/001-080/IS Rasilez HCT Iceland 17.3.2009 EU/1/08/492/001/NO-006/NO RoActemra Norway 6.2.2009 EU/1/08/492/001-006 RoActemra Liechtenstein 28.2.2009 EU/1/08/492/001-006/IS RoActemra Iceland 18.3.2009 EU/1/08/494/001/NO-002/NO Stelara Norway 9.2.2009 EU/1/08/494/001-002 Stelara Liechtenstein 28.2.2009 EU/1/08/494/001-002/IS Stelara Iceland 18.3.2009 EU/1/08/495/001/NO-008/NO Zarzio Norway 3.3.2009 EU/1/08/495/001-008 Zarzio Liechtenstein 28.2.2009 EU/1/08/495/001-008/IS Zarzio Iceland 20.3.2009 EU/1/08/496/001/NO-008/NO Filgrastim Hexal Norway 3.3.2009 EU/1/08/496/001-008 Filgrastim Hexal Liechtenstein 28.2.2009 EU/1/08/496/001-008/IS Filgrastim Hexal Iceland 20.3.2009 EU/1/08/497/001/NO Nplate Norway 2.3.2009 EU/1/08/497/001-002 Nplate (orphan) Liechtenstein 28.2.2009 EU/1/08/497/001-002/IS Nplate Iceland 24.3.2009 EU/1/08/498/001/NO-008/NO Thymanax Norway 17.4.2009 EU/1/08/498/001-008 Thymanax Liechtenstein 30.4.2009 EU/1/08/498/001-008/IS Thymanax Iceland 23.3.2009 EU/1/08/499/001/NO-008/NO Valdoxan Norway 16.4.2009 EU/1/08/499/001-008 Valdoxan Liechtenstein 30.4.2009 EU/1/08/499/001-008/IS Valdoxan Iceland 23.3.2009 EU/1/08/500/001/NO-004/NO Fablyn Norway 24.3.2009 EU/1/08/500/001-004 Fablyn Liechtenstein 30.4.2009 EU/1/08/500/001-004/IS Fablyn Iceland 24.4.2009 EU/1/08/501/001/NO-002/NO Ixiaro Norway 22.4.2009 EU/1/08/501/001-002 Ixiaro Liechtenstein 30.4.2009 EU/1/08/501/001-002/IS Ixiaro Iceland 20.5.2009 EU/1/08/502/001 Mepact (orphan drug) Liechtenstein 30.4.2009 EU/1/08/502/001/IS Mepact Iceland 19.5.2009 EU/1/08/502/001/NO Mepact Norway 12.5.2009 EU/1/08/503/001/NO-014/NO Efient Norway 1.4.2009 EU/1/08/503/001-014 Efient Liechtenstein 30.4.2009 EU/1/08/503/001-014/IS Efient Iceland 3.3.2009 EU/1/08/504/001/NO-002/NO Firmagon Norway 12.3.2009 EU/1/08/504/001-002 Firmagon Liechtenstein 28.2.2009 EU/1/08/504/001-002/IS Firmagon Iceland 13.3.2009 EU/1/08/505/001/NO-006/NO Intanza Norway 1.4.2009 EU/1/08/505/001-006 Intanza Liechtenstein 30.4.2009 EU/1/08/505/001-006/IS Intanza Iceland 21.4.2009 EU/1/08/506/001 Celvapan Liechtenstein 30.4.2009 EU/1/08/506/001/IS Celvapan Iceland 20.4.2009 EU/1/08/506/001/NO Celvapan Norway 23.3.2009 EU/1/08/507/001/NO-006/NO Idflu Norway 1.4.2009 EU/1/08/507/001-006 Idflu Liechtenstein 30.4.2009 EU/1/08/507/001-006/IS Idflu Iceland 21.4.2009 EU/1/09/508/001/NO-009/NO Synflorix Norway 22.4.2009 EU/1/09/508/001-009 Synflorix Liechtenstein 30.4.2009 EU/1/09/508/001-009/IS Synflorix Iceland 30.5.2009 EU/1/09/509/001/NO-004/NO Ribavirin Teva Norway 15.5.2009 EU/1/09/509/001-004 Ribavirin Teva Liechtenstein 30.4.2009 EU/1/09/509/001-004/IS Ribavirin Teva Iceland 23.5.2009 EU/1/09/510/001/NO-019/NO Fertavid Norway 14.5.2009 EU/1/09/510/001-019 Fertavid Liechtenstein 30.4.2009 EU/1/09/510/001-019/IS Fertavid Iceland 26.6.2009 EU/1/09/511/001/NO-004/NO Conbriza Norway 12.5.2009 EU/1/09/511/001-004 Conbriza Liechtenstein 30.4.2009 EU/1/09/511/01-04/IS Conbriza Iceland 25.6.2009 EU/1/09/512/001/NO-002/NO Removab Norway 4.5.2009 EU/1/09/512/001-002 Removab Liechtenstein 30.4.2009 EU/1/09/512/001-002/IS Removab Iceland 18.5.2009 EU/1/09/513/001/NO-020/NO Rivastigmin Teva Norway 5.5.2009 EU/1/09/513/001-020 Rivastigmin Teva Liechtenstein 30.4.2009 EU/1/09/513/001-020/IS Rivastigmin Teva Iceland 2.6.2009 EU/1/09/514/001/NO-020/NO Zebinix Norway 27.5.2009 EU/1/09/514/001-020 Zebinix Liechtenstein 30.4.2009 EU/1/09/514/001-020/IS Zebinix Iceland 30.5.2009 EU/1/09/515/001-004 Controloc Control Liechtenstein 30.6.2009 EU/1/09/516/001-004 Somac Control Liechtenstein 30.6.2009 EU/1/09/517/001-004 Pantozol Control Liechtenstein 30.6.2009 EU/1/09/518/001-004 Pantecta Liechtenstein 30.6.2009 EU/1/09/519/001-004 Pantoloc Control Liechtenstein 30.6.2009 EU/1/09/520/001/NO-020/NO Exalief Norway 27.5.2009 EU/1/09/520/001-020 Exalief Liechtenstein 30.4.2009 EU/1/09/520/001-020/IS Exalief Iceland 30.5.2009 EU/1/09/521/001-007 Renvela Liechtenstein 30.6.2009 EU/1/09/522/001/IS Ellaone Iceland 22.6.2009 EU/1/09/522/001/NO Ellaone Norway 18.6.2009 EU/1/09/522/01 Ellaone Liechtenstein 30.6.2009 EU/1/09/523/001-002 Modigraf Liechtenstein 30.6.2009 EU/1/09/524/001 Qutenza Liechtenstein 30.6.2009 EU/1/09/525/001-046 Nimvastid Liechtenstein 30.6.2009 EU/1/09/525/001-046/IS Nimvastid Iceland 26.6.2009 EU/1/09/526/001 Iressa Liechtenstein 30.6.2009 EU/1/8/491/001/NO-080/NO Razilez HCT Norway 19.2.2009 EU/107/440/001-002 Tyverb Liechtenstein 30.4.2009 EU/108/462/001-012 Ranexa Liechtenstein 30.4.2009 EU/2/06/067/001/NO-002/NO Medisinsk oksygen Norway 15.1.2009 EU/2/08/080/001/NO-004/NO Reconcile Norway 13.1.2009 EU/2/08/081/001/NO-003/NO Posatex Norway 13.1.2009 EU/2/08/082/001/NO-003/NO Zactran Norway 15.1.2009 EU/2/08/083/001/NO Equioxx Norway 4.2.2009 EU/2/08/085/001/IS Easotic Iceland 26.1.2009 EU/2/08/087/001/NO-002/NO Masivet Norway 5.1.2009 EU/2/08/088/001-004/IS Acticam Iceland 27.1.2009 EU/2/08/089/001/NO-020/NO Onsior Norway 19.1.2009 EU/2/08/089/001-020 Onsior Liechtenstein 28.2.2009 EU/2/08/089/001-020/IS Onsior Iceland 25.1.2009 EU/2/08/090/001/NO-008/NO Loxicom Norway 13.3.2009 EU/2/08/090/001-008 Loxicom Liechtenstein 28.2.2009 EU/2/08/091/001/NO-010/NO Porcilis PCV Norway 6.2.2009 EU/2/08/091/001-010 Porcilis PCV Liechtenstein 28.2.2009 EU/2/08/091/001-010/IS Porcilis PCV Iceland 2.3.2009 EU/2/08/092/001/NO-007/NO Startvac Norway 16.3.2009 EU/2/08/092/001-007 Startvac Liechtenstein 28.2.2009 EU/2/08/092/001-007/IS Startvac Iceland 24.3.2009 EU/2/09/093/001/NO-002/NO Netvax Norway 29.4.2009 EU/2/09/093/001-002 Netvax Liechtenstein 30.4.2009 EU/2/09/093/001-002/IS Netvax Iceland 30.6.2009 EU/2/09/094/001/NO-005/NO BTVPUR Norway 11.5.2009 EU/2/09/094/001-005 BTVPUR Liechtenstein 30.4.2009 EU/2/09/094/001-005/IS BTVPUR Iceland 28.5.2009 EU/2/09/095/001/NO-003/NO Improvac Norway 30.6.2009 EU/2/09/095/001-003 Improvac Liechtenstein 30.6.2009

ANNEX II List of renewed marketing authorisations The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2009: EU-Number Product Country Date of authorisation EU/1/03/263/001/NO-003/NO Dukoral Norway 27.5.2009 EU/1/03/263/001-003 Dukoral Liechtenstein 30.4.2009 EU/1/03/263/001-003/IS Dukoral Iceland 24.4.2009 EU/1/03/264/001 Zevalin Liechtenstein 28.2.2009 EU/1/03/264/001/IS Zevalin Iceland 22.2.2009 EU/1/03/265/003/NO-006/NO Bonviva Norway 17.4.2009 EU/1/03/265/003-006 Bonviva Liechtenstein 30.4.2009 EU/1/03/265/003-006/IS Bonviva Iceland 16.4.2009 EU/1/03/266/003/NO-006/NO Bondenza Norway 17.4.2009 EU/1/03/266/003-006 Bondenza Liechtenstein 30.4.2009 EU/1/03/266/003-006/IS Bondenza Iceland 16.4.2009 EU/1/03/267/001/NO-010/NO Reyataz Norway 15.4.2009 EU/1/03/267/001-010 Reyataz Liechtenstein 30.4.2009 EU/1/03/267/001-010/IS Reyataz Iceland 8.4.2009 EU/1/03/268/001/NO-004/NO Cholestagel Norway 25.5.2009 EU/1/03/268/001-004 Cholestagel Liechtenstein 30.4.2009 EU/1/03/268/001-004/IS Cholestagel Iceland 27.6.2009 EU/1/03/269/001/IS Faslodex Iceland 26.1.2009 EU/1/03/269/001/NO Faslodex Norway 3.3.2009 EU/1/03/270/001-003 Kentera Liechtenstein 30.6.2009 EU/1/03/270/001-003/IS Kentera Iceland 24.6.2009 EU/1/03/271/001/NO-006/NO Advate Norway 14.4.2009 EU/1/03/271/001-006 Advate Liechtenstein 30.4.2009 EU/1/03/271/001-006/IS Advate Iceland 27.5.2009 EU/1/04/272/001-002 PhotoBarr Liechtenstein 30.4.2009 EU/1/04/272/001-002/IS PhotoBarr Iceland 28.4.2009 EU/1/04/273/001 Lysodren Liechtenstein 30.4.2009 EU/1/04/273/001/IS Lysodren Iceland 28.5.2009 EU/1/04/273/001/NO Lysodren Norway 25.5.2009 EU/1/04/274/001/NO-002/NO Velcade Norway 5.6.2009 EU/1/04/274/001-002 Velcade Liechtenstein 30.4.2009 EU/1/04/274/001-002/IS Velcade Iceland 29.6.2009 EU/1/04/275/001-002 Litak Liechtenstein 30.4.2009 EU/1/04/275/002/IS Litak Iceland 25.6.2009 EU/1/04/276/001-020, 024-036 Abilify Liechtenstein 30.6.2009 EU/1/04/277/001-004 TachoSil Liechtenstein 30.6.2009 EU/1/04/278/001/NO-009/NO Levemir Norway 20.5.2009 EU/1/04/278/001-009 Levemir Liechtenstein 30.4.2009 EU/1/04/278/001-009/IS Levemir Iceland 26.5.2009 EU/1/04/281/001-005 Erbitux Liechtenstein 30.6.2009 EU/1/04/282/001-002 Telzir Liechtenstein 30.6.2009 EU/1/04/283/008-012 Ariclaim Liechtenstein 30.6.2009 EU/1/04/296/001-009 Cymbalta Liechtenstein 30.6.2009 EU/1/04/297/001-008 Xeristar Liechtenstein 30.6.2009 EU/1/06/367/001/NO-012/NO Diacomit Norway 5.1.2009 EU/1/06/380/001/IS Prezista Iceland 10.1.2009 EU/1/06/380/001/NO Prezista Norway 20.1.2009 EU/1/07/423/001-003 Vectibix Liechtenstein 30.4.2009 EU/1/07/436/001/NO-002/NO Isentress Norway 24.2.2009 EU/1/07/440/001/NO-002/NO Tyverb Norway 18.6.2009 EU/1/07/440/001-002/IS Tyverb Iceland 25.5.2009 EU/1/98/089/001/NO-022/NO Pritor Norway 6.1.2009 EU/1/98/090/001/NO-020/NO Micardis Norway 6.1.2009 EU/1/98/091/001/NO-014/NO Kinzalmono Norway 6.1.2009 EU/1/98/095/001/NO-004/NO Emadine Norway 2.3.2009 EU/1/98/095/001-004 Emadine Liechtenstein 28.2.2009 EU/1/98/095/001-004/IS Emadine Iceland 23.2.2009 EU/1/98/096/001/NO-012/NO Temodal Norway 5.2.2009 EU/1/98/096/001-012 Temodal Liechtenstein 28.2.2009 EU/1/98/096/001-012/IS Temodal Iceland 16.1.2009 EU/1/99/097/001 Beromun Liechtenstein 30.4.2009 EU/1/99/097/001/IS Beromun Iceland 19.5.2009 EU/1/99/097/001/NO Beromun Norway 4.6.2009 EU/1/99/099/001/NO-006/NO Zerene Norway 2.4.2009 EU/1/99/099/001-006 Zerene Liechtenstein 30.4.2009 EU/1/99/099/001-006/IS Zerene Iceland 24.3.2009 EU/1/99/100/001/NO-003/NO Cetrotide Norway 25.5.2009 EU/1/99/100/001-003 Cetrotide Liechtenstein 30.4.2009 EU/1/99/101/001 Regranex Liechtenstein 30.4.2009 EU/1/99/101/001/IS Regranex Iceland 24.6.2009 EU/1/99/101/001/NO Regranex Norway 25.5.2009 EU/1/99/102/001/NO-006/NO Sonata Norway 2.4.2009 EU/1/99/102/001-006 Sonata Liechtenstein 30.4.2009 EU/1/99/102/001-006/IS Sonata Iceland 24.3.2009 EU/1/99/103/001-004 ReFacto AF Liechtenstein 30.4.2009 EU/1/99/107/001-005 Rebetol Liechtenstein 30.4.2009 EU/1/99/107/001-005/IS Rebetol Iceland 2.6.2009 EU/1/99/110/001/NO-005/NO, 008/NO-010/NO Sustiva Norway 20.5.2009 EU/1/99/110/001-005&008-010/IS Sustiva Iceland 22.6.2009 EU/1/99/110/001-005, 008-009 Sustiva Liechtenstein 30.4.2009 EU/1/99/111/001/NO-005/NO, 008/NO-011/NO Stocrin Norway 25.5.2009 EU/1/99/111/001-005&008-011/IS Stocrin Iceland 22.6.2009 EU/1/99/111/001-005, 008-011 Stocrin Liechtenstein 30.4.2009 EU/1/99/112/001-002 Ziagen Liechtenstein 30.6.2009 EU/1/99/119/001, 003, 005-015 NovoRapid Liechtenstein 30.6.2009 EU/1/99/119/001/NO,-003/NO,-005/NO-015/NO NovoRapid Norway 16.6.2009 EU/2/03/041/001/NO-005/NO Draxxin Norway 21.1.2009 EU/2/04/042/001-006/IS Novem Iceland 14.5.2009 EU/2/04/042/005-006 Novem Liechtenstein 30.4.2009 EU/2/04/043/001 Equilis StrepE Liechtenstein 30.6.2009 EU/2/04/044/008 Aivlosin Liechtenstein 30.4.2009 EU/2/04/045/001-007 Previcox Liechtenstein 30.6.2009 EU/2/98/010/004-006,017-018,021-024 Econor Liechtenstein 30.4.2009 EU/2/98/010/010/004-014&017-018&021-024/IS Econor Iceland 16.4.2009 EU/2/99/011/001/IS Locatim Iceland 25.1.2009 EU/2/99/011/001/NO Locatim Norway 6.2.2009

ANNEX III List of extended marketing authorisations The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2009: EU-Number Product Country Date of authorisation EU/1/00/133/009-032 Optisulin Liechtenstein 30.4.2009 EU/1/00/155/007 Luveris Liechtenstein 30.6.2009 EU/1/03/255/007-008 Ventavis Liechtenstein 30.6.2009 EU/1/03/260/024/NO-033/NO Stalevo Norway 29.4.2009 EU/1/03/260/024-033/IS Stalevo Iceland 25.5.2009 EU/1/03/260/024-33 Stalevo Liechtenstein 30.4.2009 EU/1/05/315/002 Aptivus Liechtenstein 30.6.2009 EU/1/05/319/005/NO-010/NO Xolair Norway 12.5.2009 EU/1/05/319/005-010/IS Xolair Iceland 29.6.2009 EU/1/05/328/001-002/IS Cubicin Iceland 3.6.2009 EU/1/06/347/007-008 Sutent Liechtenstein 30.6.2009 EU/1/06/363/010/NO-011/NO Sprycel Norway 11.2.2009 EU/1/06/363/010-011 Sprycel Liechtenstein 28.2.2009 EU/1/06/363/010-011/IS Sprycel Iceland 22.2.2009 EU/1/06/368/143/NO-162/NO Insulin Human Winthrop Norway 15.4.2009 EU/1/06/368/143-162 Insulin Human Winthrop Liechtenstein 28.2.2009 EU/1/06/368/143-162/IS Insulin Human Winthrop Iceland 22.4.2009 EU/1/06/368/163-168 Insulin Human Winthrop Liechtenstein 30.6.2009 EU/1/06/370/034-036 Exforge Liechtenstein 30.4.2009 EU/1/06/371/034-036 Dafiro Liechtenstein 30.4.2009 EU/1/06/372/034-036 Copalia Liechtenstein 30.4.2009 EU/1/06/373/034-036 Imprida Liechtenstein 30.4.2009 EU/1/06/380/002/NO-003/NO Prezista Norway 24.2.2009 EU/1/06/380/002-003 Prezista Liechtenstein 28.2.2009 EU/1/06/380/002-003/IS Prezista Iceland 13.5.2009 EU/1/06/380/004-005 Prezista Liechtenstein 30.6.2009 EU/1/07/387/011/NO-013/NO Advagraf Norway 4.6.2009 EU/1/07/387/011-013 Advagraf Liechtenstein 30.4.2009 EU/1/07/387/011-013/IS Advagraf Iceland 24.6.2009 EU/1/07/388/003 Sebivo Liechtenstein 28.2.2009 EU/1/07/388/003/IS Sebivo Iceland 20.3.2009 EU/1/07/388/003/NO Sebivo Norway 14.5.2009 EU/1/07/395/065-095 Invega Liechtenstein 28.2.2009 EU/1/07/395/077/NO-095/NO Invega Norway 5.3.2009 EU/1/07/395/077-095/IS Invega Iceland 27.2.2009 EU/1/07/401/007/NO-010/NO Alli Norway 12.2.2009 EU/1/07/401/007-010 Alli Liechtenstein 28.2.2009 EU/1/07/401/007-010/IS Alli Iceland 19.3.2009 EU/1/08/446/004 Privigen Liechtenstein 30.6.2009 EU/1/08/454/005 Extavia Liechtenstein 30.4.2009 EU/1/08/455/015-016 Janumet Liechtenstein 30.6.2009 EU/1/08/456/015-016 Velmetia Liechtenstein 30.6.2009 EU/1/08/457/015-016 Efficib Liechtenstein 30.6.2009 EU/1/08/458/012-014 Trevaclyn Liechtenstein 30.6.2009 EU/1/08/459/012-014 Tredaptive Liechtenstein 30.6.2009 EU/1/08/460/012-014 Pelzont Liechtenstein 30.6.2009 EU/1/08/464/018-019 Clopidogrel BMS Liechtenstein 28.2.2009 EU/1/08/465/018-019 Clopidogrel Winthrop Liechtenstein 28.2.2009 EU/1/97/030/170/NO-189/NO Insuman Norway 8.4.2009 EU/1/97/030/170-189 Insuman Liechtenstein 30.4.2009 EU/1/97/030/170-189/IS Insuman Iceland 22.4.2009 EU/1/97/030/190-195 Insuman Liechtenstein 30.6.2009 EU/1/97/055/004 Viramune Liechtenstein 30.6.2009 EU/1/98/063/008/NO-10/NO Rebif Norway 9.2.2009 EU/1/98/063/008-010 Rebif Liechtenstein 28.2.2009 EU/1/98/063/008-010/IS Rebif Iceland 18.3.2009 EU/1/98/069/011a-011b Plavix Liechtenstein 28.2.2009 EU/1/98/070/011a-011b Iscover Liechtenstein 28.2.2009 EU/1/98/096/013-023 Temodal Liechtenstein 28.2.2009 EU/1/98/096/023/IS Temodal Iceland 24.3.2009 EU/1/98/096/023/NO Temodal Norway 18.3.2009 EU/1/99/110/010 Sustiva Liechtenstein 30.4.2009 EU/1/99/116/004-005 Remicade Liechtenstein 30.4.2009 EU/1/99/123/013 Renagel Liechtenstein 30.6.2009 EU/2/04/044/009-010 Aivlosin Liechtenstein 30.6.2009 EU/2/06/058/004/IS Flexicam Iceland 27.1.2009 EU/2/07/078/004 Rheumocam Liechtenstein 30.6.2009

ANNEX IV List of withdrawn marketing authorisations The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2009: EU-Number Product Country Date of withdrawal EU/1/01/184/001/NO-073/NO Nespo Norway 11.3.2009 EU/1/01/184/001-073/IS Nespo Iceland 24.1.2009 EU/1/01/211/001/NO-012/NO Dynepo Norway 18.5.2009 EU/1/02/211/001-005&010-012/IS Dynepo Iceland 14.4.2009 EU/1/02/211/001-005,010-012 Dynepo Liechtenstein 30.4.2009 EU/1/02/228/001-003/IS Neupopeg Iceland 24.1.2009 EU/1/02/232/001-003 Velosulin Liechtenstein 28.2.2009 EU/1/02/232/001-003/IS Velosulin Iceland 18.3.2009 EU/1/04/291/001-003 Raptiva Liechtenstein 30.6.2009 EU/1/04/291/001-003/IS Raptiva Iceland 27.4.2009 EU/1/04/293/001/NO-012/NO Parareg Norway 12.3.2009 EU/1/04/293/001-012/IS Parareg Iceland 23.1.2009 EU/1/06/344/001/NO-011/NO Acomplia Norway 11.3.2009 EU/1/06/344/001-011 Acomplia Liechtenstein 28.2.2009 EU/1/06/344/001-011/IS Acomplia Iceland 23.1.2009 EU/1/06/345/001/NO-011/NO Zimulti Norway 13.2.2009 EU/1/06/345/001-011 Zimulti Liechtenstein 28.2.2009 EU/1/06/345/001-011/IS Zimulti Iceland 23.1.2009 EU/1/99/102/007/NO-008/NO Sonata Norway 2.4.2009 EU/1/99/110/006/NO-007/NO Sustiva Norway 20.5.2009 EU/1/99/111/006/NO-007/NO Stocrin Norway 25.5.2009